about
The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicingA comprehensive biochemical and genetic analysis of the yeast U1 snRNP reveals five novel proteins.Interaction of the U1 snRNP with nonconserved intronic sequences affects 5' splice site selection.IRES-mediated functional coupling of transcription and translation amplifies insulin receptor feedbackTranscriptional feedback control of insulin receptor by dFOXO/FOXO1.siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipidsFoxo and Fos regulate the decision between cell death and survival in response to UV irradiation.Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.Nutrient availability and growth: regulation of insulin signaling by dFOXO/FOXO1.FOXO-regulated transcription restricts overgrowth of Tsc mutant organsDrosophila FoxO regulates organism size and stress resistance through an adenylate cyclase.Understanding Forkhead box class O function: lessons from Drosophila melanogaster.Systems biology approach for new target and biomarker identification.Gene expression in human NAFLD.Antitumor activity of alectinib, a selective ALK inhibitor, in an ALK-positive NSCLC cell line harboring G1269A mutation: Efficacy of alectinib against ALK G1269A mutated cells.dFOXO regulates transcription of a Drosophila acid lipase.Large rearrangements of the LDL receptor gene and lipid profile in a FH Spanish population.A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status.Evaluating genetic ancestry and self-reported ethnicity in the context of carrier screening.Transcriptome profiling and network analysis of genetically hypertensive mice identifies potential pharmacological targets of hypertension.A single point mutation in the low-density lipoprotein receptor switches the degradation of its mature protein from the proteasome to the lysosome.Characterization of the Drosophila insulin receptor promoter.Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab.High-resolution dynamics of the transcriptional response to nutrition in Drosophila: a key role for dFOXO.Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma.Molecular genetics of familial hypercholesterolemia in Spain: Ten novel LDLR mutations and population analysisErratum to: Translational Biomarkers: from Preclinical to Clinical a Report of 2009 AAPS/ACCP Biomarker WorkshopCase-control Indian buffet process identifies biomarkers of response to CodrituzumabSeven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in SpainA three-allelic polymorphic system in exon 12 of the LDL receptor gene is highly informative for segregation analysis of familial hypercholesterolemia in the Spanish populationPlasma Lp(a) values in familial hypercholesterolemia and its relation to coronary heart diseaseInteraction between N-terminal domain of H4 and DNA is regulated by the acetylation degree[Familial hypercholesterolemia: molecular identification and characterization of the first compound homozygote in Spain]Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire familyComprehensive genetic testing for female and male infertility using next-generation sequencing
P50
Q24290594-1706C9F0-F3B0-4E3E-8202-1520313A0C57Q27934040-528002BA-396E-412C-83FC-9270F5054021Q27936014-D6DD60D3-931D-4EE1-9637-67CA725EA7E0Q28763839-FE52D197-E3ED-4E26-B515-9FFAD069DE57Q34084120-46F82143-1C28-423D-965A-4C4D5FC7D77BQ34955791-39A93897-DE09-42AA-A275-B78469E3148EQ35612440-E4A98AEC-01EF-47A8-B2FA-C827FC187160Q35952700-3703B605-1EC9-4963-A908-AC941E1847B1Q36427770-31533E4F-D138-4DB8-8AF8-AC2EEB0A7BBCQ36492071-8948FCB4-B158-4409-B831-5F44F75819AFQ37355975-4EFA915F-8142-4D59-BC54-09381581A738Q37771335-7D884E49-C552-4AB4-9E24-DA9F853F4DB4Q38035767-3B57085B-CF1C-4C3B-8A44-7E6D9ACF34A7Q38292078-20BDFEFE-3029-4108-84C9-8D2ED222566DQ38796226-BE24D556-6066-4E35-B4C0-D9865C52F600Q40018890-519E2DCF-57CB-4B98-A46D-F4F4A354048FQ43557807-4600AB70-1B71-456A-8A36-E4BDDEEB853CQ44934933-F0A6381B-1386-4D56-8F1C-4EF6D7C103EBQ45943062-46704D94-165F-44E8-B83C-D780427D915EQ45944027-06B9F4E5-E41C-4B96-A075-11F7E2F96C46Q46985784-D09E1675-83CD-40C1-9FD0-7EEC83C31C7CQ51987778-F9B9145D-DAC9-4097-B6DF-EDF209CE8A31Q52657092-61922800-6FF7-4599-87F3-726020B7F472Q52674016-0EC2656C-A049-4A38-9DED-1BFE1C9CC465Q53162619-8EBC2EAC-EE5E-457B-9078-6C932E92201BQ57837960-12BEEAFB-0172-4667-BCE0-22CF9899F81CQ58869611-D54A6668-5D84-4C6A-873F-6E285BA60916Q64106020-00EAB88C-56F6-4CE0-94EE-0FC161FACED7Q71725568-CFDED767-62DB-4B6D-8AF0-35C7AEC12414Q71725578-0220B129-C4F8-49FE-A931-B87F7605244FQ73568037-BC380CF1-4C65-4B9B-9A67-A0B6BA6581C4Q74450891-18354C95-B04B-4B88-B971-3E71725A5E0BQ74498738-D2CEE7B1-791A-4938-BC36-05A23368F73AQ84829637-1C31FFB8-8F3B-49B1-8DE3-E938D3A5FE00Q88739039-6A9634A7-FD06-4858-9418-66EEEA080CD7
P50
description
researcher
@en
wetenschapper
@nl
name
O Puig
@en
O Puig
@nl
type
label
O Puig
@en
O Puig
@nl
prefLabel
O Puig
@en
O Puig
@nl
P106
P31
P496
0000-0003-0918-2528